Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan W Lischalk

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Frontiers in Oncology|November 30, 2020
Management of Isolated Local Failures Following Stereotactic Body Radiation Therapy for Low to Intermediate Risk Prostate CancerNima Aghdam, Abigail N Pepin, Michael Creswell, et al.
Frontiers in Oncology|January 30, 2023
High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodesTanja Eichkorn, Jonathan W Lischalk, Cedric Stüwe, et al.
Neuro-Oncology Advances|October 22, 2024
Analysis of safety and efficacy of proton radiotherapy for optic nerve sheath meningiomaMaximilian Y Deng, Sophie Rauh, Günes Anil, et al.
Neuro-Oncology|December 11, 2023
Efficacy and toxicity of bimodal radiotherapy in WHO grade 2 meningiomas following subtotal resection with carbon ion boost: Prospective phase 2 MARCIE trialMaximilian Y Deng, Sybren L N Maas, Felix Hinz, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Frontiers in Oncology|November 30, 2020
Management of Isolated Local Failures Following Stereotactic Body Radiation Therapy for Low to Intermediate Risk Prostate CancerNima Aghdam, Abigail N Pepin, Michael Creswell, et al.
Frontiers in Oncology|January 30, 2023
High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodesTanja Eichkorn, Jonathan W Lischalk, Cedric Stüwe, et al.
Neuro-Oncology Advances|October 22, 2024
Analysis of safety and efficacy of proton radiotherapy for optic nerve sheath meningiomaMaximilian Y Deng, Sophie Rauh, Günes Anil, et al.
Neuro-Oncology|December 11, 2023
Efficacy and toxicity of bimodal radiotherapy in WHO grade 2 meningiomas following subtotal resection with carbon ion boost: Prospective phase 2 MARCIE trialMaximilian Y Deng, Sybren L N Maas, Felix Hinz, et al.
Pageof 7